LHC Group (NASDAQ:LHCG) is a financially sound national provider of post-acute care, offering quality and cost-effective healthcare to patients within the comfort of their home. After a more than 12% drop last Friday, the shares of LHC Group are trading at a market cap of $328.98 million, which is close to the company's book value of $274.59 million. In this article I'll explain why the recent drop in the share price offers an incredible buying opportunity for medium-term investors, with a moderate risk-tolerance level. I believe the stock has very limited downside of not more than 5% from the current level against an approximately 40% potential upside within the next year.
Why Does This Opportunity Exist?
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|